CLOUGH CAPITAL PARTNERS L P

Position in LLY — ELI LILLY & Co

CIK 1276144 Boston, MA

Position in LLY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$25,285,185

+$15,639,071 QoQ

Shares Held

21,081

+93.6% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

2.06%

of 13F equity value

Holder Rank

#793

of 4,605 holders

Holding Since

Mar 2020

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CLOUGH CAPITAL PARTNERS L P holds $44,798,668 across 4 Drug Manufacturers - General names. LLY ranks #1 (56.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	21,081	$25,285,185
2	NVO	Novo Nordisk A S	373,977	$17,928,457
3	GILD	Gilead Sciences, Inc.	6,300	$795,942
4	JNJ	Johnson & Johnson	3,107	$789,084

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$25,285,185	21,081	+93.6%	Shares	Defined	2026-08-14
2024-09-30	$9,646,114	10,888	-60.8%	Shares	Defined	2024-11-14
2024-06-30	$25,162,320	27,792	+5.2%	Shares	Defined	2024-08-14
2024-03-31	$20,549,813	26,415	+98.3%	Shares	Defined	2024-05-15
2023-03-31	$4,574,354	13,320	+37.3%	Shares	Defined	2023-05-15
2022-12-31	$3,548,648	9,700	+61.3%	Shares	Defined	2023-02-14
2022-06-30	$1,949,594	6,013	-49.9%	Shares	Defined	2022-08-16
2022-03-31	$3,440,162	12,013	0.0%	Shares	Defined	2022-05-16
2021-12-31	$3,318,230	12,013	0.0%	Shares	Defined	2022-02-14
2021-09-30	$2,775,603	12,013	0.0%	Shares	Defined	2021-11-15
2021-06-30	$2,757,223	12,013	+30.4%	Shares	Defined	2021-08-16
2021-03-31	$1,721,172	9,213	0.0%	Shares	Defined	2021-05-17
2020-12-31	$1,555,522	9,213	0.0%	Shares	Defined	2021-02-16
2020-09-30	$1,363,708	9,213	0.0%	Shares	Defined	2020-11-17
2020-06-30	$1,512,590	9,213	+24.3%	Shares	Defined	2020-08-14
2020-03-31	$1,028,331	7,413	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.